scholarly article | Q13442814 |
P356 | DOI | 10.1021/JF200418G |
P698 | PubMed publication ID | 21456596 |
P2093 | author name string | Yueh-Hsiung Kuo | |
Chin Hsu | |||
Ching-jang Huang | |||
Chin-Lin Hsieh | |||
P2860 | cites work | Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica | Q33934615 |
Cucurbitane triterpenoids from Momordica charantia and their cytoprotective activity in tert-butyl hydroperoxide-induced hepatotoxicity of HepG2 cells | Q42783631 | ||
Octanorcucurbitane triterpenoids protect against tert-butyl hydroperoxide-induced hepatotoxicity from the stems of Momordica charantia. | Q43179304 | ||
Momordica charantia constituents and antidiabetic screening of the isolated major compounds. | Q54231332 | ||
Cucurbitane triterpenoids from Momordica charantia | Q80152759 | ||
Structures of New Cucurbitane-Type Triterpenes and Glycosides, Karavilagenins D and E, and Karavilosides VI, VII, VIII, IX, X, and XI, from the Fruit of Momordica charantia | Q104950509 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | estrogen | Q277954 |
Momordica charantia | Q428750 | ||
P1104 | number of pages | 9 | |
P304 | page(s) | 4553-4561 | |
P577 | publication date | 2011-04-11 | |
P1433 | published in | Journal of Agricultural and Food Chemistry | Q1024905 |
P1476 | title | Isolation and identification of cucurbitane-type triterpenoids with partial agonist/antagonist potential for estrogen receptors from Momordica charantia | |
P478 | volume | 59 |
Q28486994 | Activation of AMPK by bitter melon triterpenoids involves CaMKKβ |
Q35231058 | Anti-inflammatory effect of Momordica charantia in sepsis mice |
Q38822006 | Artepillin C and Other Herbal PAK1-blockers: Effects on Hair Cell Proliferation and Related PAK1-dependent Biological Function in Cell Culture. |
Q46799064 | Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade. |
Q28817944 | Bitter melon: a panacea for inflammation and cancer |
Q34691591 | Effect of wild bitter gourd treatment on inflammatory responses in BALB/c mice with sepsis |
Q38907047 | Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy |
Q36752298 | Role of GLP-1 in the Hypoglycemic Effects of Wild Bitter Gourd |
Q42128185 | The anti-adiposity effect of bitter melon seed oil is solely attributed to its fatty acid components. |
Q45803559 | The effect of Momordica charantia intake on the estrogen receptors ESRα/ESRβ gene levels and apoptosis on uterine tissue in ovariectomy rats. |
Q36494764 | Unifying mechanisms of action of the anticancer activities of triterpenoids and synthetic analogs |
Q38779824 | Wild Bitter Melon Leaf Extract Inhibits Porphyromonas gingivalis-Induced Inflammation: Identification of Active Compounds through Bioassay-Guided Isolation. |